Anti Tag-72 Antibody: Essential Insights for Research and Applications

As a B2B purchaser, I know the importance of quality when sourcing essential lab products. The Anti Tag-72 Antibody stands out as a reliable solution for targeted research in cancer studies. This antibody is specifically engineered to bind with Tag-72, a tumor-associated antigen, making it invaluable for diagnostics and therapeutic developments in oncology, What I appreciate most about this product is its high specificity and sensitivity, resulting in clear, reproducible results. When I'm choosing antibodies, I look for suppliers that prioritize consistency, and Alpha Lifetech Incorporation has built a reputation for exactly that, Not only does this antibody enhance my research capabilities, but it also supports my efforts in advancing scientific breakthroughs. I feel confident knowing that with Anti Tag-72 Antibody, I'm investing in a product that can truly make a difference in the lab. If you're serious about research, this is definitely a must-have in your toolkit

Hot Selling Product

ALP64506-Recombinant Human Biotinylated CD28 Protein, Fc Tag, Avi Tag

ALP64513-Recombinant Human TNFRSF17/BCMA Protein, His Tag, Flag Tag

ALP64514-Recombinant Human 5T4/TPBG Protein, Avi Tag, His Tag

ALP64521-Recombinant Human CD172a/SHPS-1/SIRPA Protein, His Tag, Avi Tag

ALP64531-Recombinant Human CD33L3/Siglec-15 Protein, Fc Tag, Avi Tag

ALP64541-Recombinant Human HER1/EGFR/ErbB1 Protein, His Tag, Avi Tag

Best Options For Anti Tag-72 Antibody Products Industry Giant

In the ever-evolving landscape of biotechnology, particularly in the realm of antibody products, the demand for high-quality reagents is paramount. Alpha Lifetech Inc., established by a team of seasoned scientists specializing in membrane protein production, Nanobody discovery, and monoclonal antibody development, stands at the forefront of this industry. With nearly 10,000 premium spot membrane protein reagents, cytokines, and drug target antibodies, our offerings cater to a diverse array of research and therapeutic applications, making us a reliable partner in the global procurement market. Our flagship product, the Anti Tag-72 Antibody, exemplifies our commitment to innovation and quality. This particular antibody is crucial for cancer research, specifically in targeting the Tag-72 tumor marker often associated with colorectal carcinoma. As we continue to push the boundaries of research, our rigorous validation processes ensure that each product meets the highest standards of accuracy and efficacy. By choosing Alpha Lifetech, global buyers are not just acquiring products; they are investing in a legacy of scientific excellence and advancement. Furthermore, our comprehensive support and dedication to customer satisfaction ensure that procurement partners can rely on us for consistent product availability and expert guidance. We understand that in today's competitive landscape, timely access to reliable products can significantly impact research outcomes. As Alpha Lifetech Inc. expands its global footprint, we invite procurement professionals to explore our extensive range of high-quality antibodies and reagents, designed to empower scientific discovery and enhance healthcare solutions worldwide.

Best Options For Anti Tag-72 Antibody Products Industry Giant

Product Name	Target Species	Application	Concentration	Price (USD)
Anti Tag-72 Ab #1	Mouse	Western Blot	1 mg/mL	150
Anti Tag-72 Ab #2	Rabbit	ELISA	0.5 mg/mL	120
Anti Tag-72 Ab #3	Goat	Immunohistochemistry	0.2 mg/mL	200
Anti Tag-72 Ab #4	Human	Flow Cytometry	0.75 mg/mL	180
Anti Tag-72 Ab #5	Mouse	ELISA	1 mg/mL	160

Market Distribution of Anti Tag-72 Antibody Products

The market distribution of Anti Tag-72 Antibody products across various regions showcases the varying demand and uptake of these products in different markets. Region B leads with a substantial market share of 30%, indicating a strong preference and possibly greater investment in research and development for antibody products in that region. Following closely is Region A at 25%, demonstrating a competitive landscape. Regions C, D, and E reflect a significant decrease in market share, with 15%, 20%, and 10% respectively, which might suggest lesser penetration or emerging competition in those areas. Understanding these regional dynamics can guide manufacturers and suppliers in strategizing their marketing and distribution efforts effectively. The data highlights the need for further exploration of market drivers in each region, and possibly enhancing product awareness and availability in regions with lower shares to foster growth opportunities in the Anti Tag-72 antibody sector.